Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NICOTROL NS 10 MG/ML SPRAY

nicotine
$12.9657per ML
High Outlier

Strength

10 mg/mL

Manufacturer

Pharmacia & Upjohn Company LLC

NDC

00009540101

Classification

Brand

Dosage Form

SPRAY, METERED

Route

NASAL

Last Updated

4/22/2026

Active Ingredients

NICOTINE

Approval Type

New Drug (NDA)

FDA Application

NDA020385

On Market Since

5/22/1996

Pharmacological Classes

Cholinergic Nicotinic Agonist
Nicotine

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.2%

3Y

+1.5%

5Y

+13.3%

All

+137.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

NICORETTE 4 MG LOZENGE
Brand
00135051101•Haleon US Holdings LLC
$0.4023
per EA
NICORETTE 4 MG LOZENGE
Brand
00135051106•Haleon US Holdings LLC
$0.4023
per EA
NICORETTE 4 MG LOZENGE
Brand
00135051107•Haleon US Holdings LLC
$0.4023
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135015707•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135015710•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135015711•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135022905•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135024102•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135024105•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135024106•Haleon US Holdings LLC
$0.4055
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy